IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

British Journal of Haematology

Volumn 145, Issue 1, 2009, Pages 64-72

  Kordasti, Shahram Y ^a   Afzali, Behdad ^a   Lim, Ziyi ^a   Ingram, Wendy ^a   Hayden, Janet ^a   Barber, Linda ^a   Matthews, Katie ^b   Chelliah, Rajani ^a   Guinn, Barbara ^a   Lombardi, Giovanna ^a   Farzaneh, Farzin ^a   Mufti, Ghulam J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

CD4+ T cells; Myelodysplastic syndrome; Pro inflammatory cytokines; Regulatory T cells; Th17

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; RANTES; TRANSCRIPTION FACTOR FOXP3;

5Q- SYNDROME; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD DONOR; BLOOD SAMPLING; BONE MARROW CELL; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOGENETICS; CYTOKINE RELEASE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; NICK END LABELING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; TH17 CELL;

AGED; APOPTOSIS; BONE MARROW CELLS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CHEMOKINE CCL5; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-7; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTORS, INTERLEUKIN-2; RISK; STATISTICS, NONPARAMETRIC;

EID: 61849168098     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07593.x     Document Type: Article

References (29)

1. Afzali, B., Lombardi, G., Lechler, R.I. Lord, G.M. (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology, 148, 32 46.
2. Ahmadzadeh, M. Rosenberg, S.A. (2006) IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood, 107, 2409 2414.
3. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L. Kuchroo, V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235 238.
4. Brada, S.J., van de Loosdrecht, A.A., Koudstaal, J., de Wolf, J.T. Vellenga, E. (2004) Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome. Leukemia Research, 28, 921 925.
5. Cheson, B.D., Bennett, J.M., Kantarjian, H., Pinto, A., Schiffer, C.A., Nimer, S.D., Lowenberg, B., Beran, M., de Witte, T.M., Stone, R.M., Mittelman, M., Sanz, G.F., Wijermans, P.W., Gore, S. Greenberg, P.L. (2000) Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood, 96, 3671 3674.
6. Dalamaga, M., Lekka, A., Karmaniolas, K., Stathopoulou, E. Dionyssiou-Asteriou, A. (2008) Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome? Cancer Causes and Control, 19, 371 378.
7. Dhodapkar, K.M., Barbuto, S., Matthews, P., Kukreja, A., Mazumder, A., Vesole, D., Jagannath, S. Dhodapkar, M.V. (2008) Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood, 112, 2878 2885.
8. Epling-Burnette, P.K., Painter, J.S., Rollison, D.E., Ku, E., Vendron, D., Widen, R., Boulware, D., Zou, J.X., Bai, F. List, A.F. (2007a) Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia, 21, 659 667.
9. Epling-Burnette, P.K., Bai, F., Painter, J.S., Rollison, D.E., Salih, H.R., Krusch, M., Zou, J., Ku, E., Zhong, B., Boulware, D., Moscinski, L., Wei, S., Djeu, J.Y. List, A.F. (2007b) Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood, 109, 4816 4824.
10. Evans, H.G., Suddason, T., Jackson, I., Taams, L.S. Lord, G.M. (2007) Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proceedings of the National Academy of Sciences of the United States of America, 104, 17034 17039.
11. Fantini, M.C., Rizzo, A., Fina, D., Caruso, R., Becker, C., Neurath, M.F., Macdonald, T.T., Pallone, F. Monteleone, G. (2007) IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. European Journal of Immunology, 37, 3155 3163.
12. Kiladjian, J.J., Bourgeois, E., Lobe, I., Braun, T., Visentin, G., Bourhis, J.H., Fenaux, P., Chouaib, S. Caignard, A. (2006) Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia, 20, 463 470.
13. Kitagawa, M., Saito, I., Kuwata, T., Yoshida, S., Yamaguchi, S., Takahashi, M., Tanizawa, T., Kamiyama, R. Hirokawa, K. (1997) Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia, 11, 2049 2054.
14. Kordasti, S.Y., Ingram, W., Hayden, J., Darling, D., Barber, L., Afzali, B., Lombardi, G., Wlodarski, M.W., Maciejewski, J.P., Farzaneh, F. Mufti, G.J. (2007) CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood, 110, 847 850.
15. Kotsianidis, I., Bouchliou, I., Nakou, E., Spanoudakis, E., Margaritis, D., Christophoridou, A.V., Anastasiades, A., Tsigalou, C., Bourikas, G., Karadimitris, A. Tsatalas, C 2008) Kinetics, function and bone marrow trafficking of CD4(+)CD25(+)FOXP3(+) regulatory T cells in myelodysplastic syndromes (MDS). Leukemia, doi
16. Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A. Zou, W. (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. Journal of Immunology, 178, 6730 6733.
17. Malcovati, L., Porta, M.G., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., Lazzarino, M. Cazzola, M. (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. Journal of Clinical Oncology, 23, 7594 7603.
18. Mangan, P.R., Harrington, L.E., O'Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., Hatton, R.D., Wahl, S.M., Schoeb, T.R. Weaver, C.T. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441, 231 234.
19. Mundle, S.D., Reza, S., Ali, A., Mativi, Y., Shetty, V., Venugopal, P., Gregory, S.A. Raza, A. (1999) Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes. Cancer Letters, 140, 201 207.
20. Oukka, M. (2007) Interplay between pathogenic Th17 and regulatory T cells. Annals of the Rheumatic Diseases, 66 (Suppl. 3 87 90.
21. Parker, J.E., Mufti, G.J., Rasool, F., Mijovic, A., Devereux, S. Pagliuca, A. (2000) The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood, 96, 3932 3938.
22. Raza, A., Gezer, S., Mundle, S., Gao, X.Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S. Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268 276.
23. Solomou, E.E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A.J. Young, N.S. (2007) Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood, 110, 1603 1606.
24. Steinman, L. (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nature Medicine, 13, 139 145.
25. Vardiman, J.W., Harris, N.L. Brunning, R.D. (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 100, 2292 2302.
26. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. Stockinger, B. (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity, 24, 179 189.
27. Wlodarski, M.W., O'Keefe, C., Howe, E.C., Risitano, A.M., Rodriguez, A., Warshawsky, I., Loughran, T.P., Jr. Maciejewski, J.P. (2005) Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood, 106, 2769 2780.
28. Wlodarski, M.W., Gondek, L.P., Nearman, Z.P., Plasilova, M., Kalaycio, M., Hsi, E.D. Maciejewski, J.P. (2006) Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome. Blood, 108, 2632 2641.
29. Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H. Maslinski, W. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. Journal of Immunology, 164, 2832 2838.